USPTO Fee Rule Upends 170 Years Of History, Fed Circ. Told

A drugmaker at the center of a closely watched case over whether patent and trademark applicants must pay the U.S. Patent and Trademark Office's legal bills fired its opening shot Tuesday...

Already a subscriber? Click here to view full article